Sign In
Sign Up
Two Blokes
AstraZeneca Meets All Key Goals in Phase III Hypertension Study
click to rate
Posted by
Two Blokes
Jul 15
- Filed in
Stock
- 1 view
AZN hits all endpoints in phase III study for baxdrostat, a first-in-class treatment targeting hard-to-manage hypertension.
